RHYTHM PHARMACEUTICALS, INC. — Director's Dealing 2022

Jul 6, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RHYTHM PHARMACEUTICALS, INC. (RYTM)
CIK: 0001649904
Period of Report: 2022-06-30

Reporting Person: Smith Hunter C (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-06-30	Common Stock	M	25000	—	Acquired	65161	Direct
2022-07-01	Common Stock	S	7547	$4.08	Disposed	57614	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-06-30	Restricted Stock Units	$	M	25000	Disposed		Common Stock (25000)	Direct

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.

F2: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 instruction solely with the intent to cover withholding taxes in connection with the vesting of certain previously reported Restricted Share Units.

F3: On June 30, 2020, the Reporting Person was granted 25,000 restricted stock units, which vested in full on June 30, 2022. The restricted stock units have no expiration date.